"10.1371_journal.pone.0102684","plos one","2014-08-19T00:00:00Z","Kirston M Barton; Nancie M Archin; Kara S Keedy; Amy S Espeseth; Yan-ling Zhang; Jennifer Gale; Florence F Wagner; Edward B Holson; David M Margolis","Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: KMB NMA KSK DMM YLZ JPG. Performed the experiments: KMB NMA KSK YLZ JPG. Analyzed the data: KMB NMA KSK DMM YLZ JPG. Contributed reagents/materials/analysis tools: ASE FFW EBH YLZ JPG. Wrote the paper: KMB NMA DMM.","D.M.M. is a consultant for and has received grants from Merck Research Laboratories. A.S.E. is an employee of Merck Research Laboratories. E.B.H. is named on patents for HDAC inhibitors held by the Broad Institute and is an equity holder at KDAc Therapeutics. E.B.H. and F.F.W. are both consultants to KDAc Therapeutics, which has licensed the patent estate around HDAC3 selective compounds and HDAC inhibitors. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. All remaining authors declare no conflicts of interest.","2014","08","Kirston M Barton","KMB",9,TRUE,6,5,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
